Skip to content

A pilot study of potential role of Liver X receptor in nonalcoholic steatohepatitis

A pilot study of potential role of Liver X receptor in nonalcoholic steatohepatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000900
Enrollment
60
Registered
2013-10-28
Start date
2013-11-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria -20 years to 70 years -clinically diagnosed for nonalcoholic liver disease -diagnosed for fatty liver by ultrasonography or CT -serum ALT or AST is greater than 40 IU/L

Exclusion criteria

Exclusion criteria: Exclusion criteria -alcohol intake (> 140g/week in man, >70g/week in woman) -diabetes requiring insulin therapy -immuno-suppressive therapy (ex. steroid) -serum creatinine of 5.0 mg/dL or greater -hepatitis B as defined by presence of hepatitis B surface antigen -hepatitis C as defined by presence of HCV-RNA or positive hepatitis C antibody -any suspicion of other liver disease such as autoimmune hepatitis

Design outcomes

Primary

MeasureTime frame
comparison of LXR expression between NASH, NAFLD and control group

Secondary

MeasureTime frame
1. clinical characteristics as expression level of LXR;2. correlation of NPC1L1, ABCG5/8, ABCA1, SREBP-1C expression;3. compare the previous studies with animals and this study with human liver samples

Countries

Korea, Republic of

Contacts

Public ContactDAE WON JUN

Hanyang University Seoul Hospital

noshin@hanyang.ac.kr+82-2-2290-8338

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026